期刊文献+

慢性荨麻疹过敏原分布及脱敏治疗疗效评估 被引量:17

The distribution of allergens and effect assessment of specific immunotherapy in chronic urticaria
原文传递
导出
摘要 目的了解慢性荨麻疹过敏原分布情况,评估脱敏治疗效果。方法收集2007年-2010年间120例慢性荨麻疹患者资料,脱敏治疗1年、2年后,按基本控制、显效、有效、无效4个等级评估治疗效果。结果吸入性过敏原前5名依次是粉尘螨(83%)、春季花粉(51%)、夏秋花粉(48%)、多价真菌(47%)、蟑螂(46%)。仅单一过敏原阳性23例(19%),2种过敏原阳性27例(23%),3种及以上过敏原阳性70例(58%),青少年和老年组单一过敏原比例(分别为40%、46%)较青中年高;不论病程长短,均是多种过敏原阳性多见。脱敏治疗1年后,总有效率为72%,脱敏治疗2年后无效组症状无明显改善。结论慢性荨麻疹过敏原主要以尘螨多见,其次是花粉、真菌、蟑螂,并且多种过敏原同时阳性多见。脱敏治疗1年效果评估,可以作为慢性荨麻疹脱敏治疗方案是否继续的重要依据。 Objective To investigate the distribution of allergens and evaluate the effect of specific immunotherapy in chronic urticaria. Methods Case records of 120 patients with chronic curticaria during the years 2007 to 2010 were re- viewed. The treatment effect of specific immunotherapy was respectively recorded after the first year and second year, and invided into 4 rating effect:basic control, markedly effect, effect, ineffect. Results The positive rate was 83% for dust mite,51% for spring pollen, 48% for autumnal pollen,47% for multivalent fungi, 46% for cockroach . 23 cases( 19% ) of the patients had positive test responses to 1 allergen, 27 cases(23% ) to 2 allergens and 70 cases(58% )to 3 or more aller- gens. the single-allergen rate of young adult and the elderly (40% ,46% ) was higher than adolescent (7%). Regardless of disease duration, multiple allergens are most common. The total effective rate of specific immunotberapy after the first year was 72%, there was no significant improvement of symptoms after the second year. Conclusions Dust mites is com- mon allergens of chronic urticaria, followed by pollen, fungi and cockroaches. Multiple allergens are most common; the effect assessment of specific immunotherapy after the first year is the important basis, whether it continues specific immuno- therapy or not.
出处 《中华疾病控制杂志》 CAS 北大核心 2013年第11期985-987,共3页 Chinese Journal of Disease Control & Prevention
关键词 荨麻疹 过敏 脱敏法 免疫 Urticaria Anaphylaxis Desensitization, immunologic
  • 相关文献

参考文献10

  • 1Greaves MW. Chronic idiopathic urticaria [ J ]. Curr Opin Allergy Clin Immunol, 2003,3 (5) :363-368.
  • 2Ye ST,Zhang HY, Wen SM, et al. Allergology [M]. Beijing: Science Press, 1998.
  • 3Caliskaner Z, Ozturk S, Turan M, et al. Skin test positivity to aeroallergens in the patients with chronic urticaria without aller-gic respiratory disease [ Jl. J Investig Allergol Clin Immunol, 2004, 14( 1 ) :50-54.
  • 4Mahesh PA, Kushalappa PA, Holla AD, et al. House dust mite sensitivity is a factor in chronic urticaria [ J 1. Indian J Dermatol Venereol Leprol, 2005,71 (2) :99-101.
  • 5Jeong KY, Hwang H, Lee J, et al. Allergenic characterization of trepomy-osin from the dusky brown cockroach, Perlplaneta fuligi- nasa [ J. Clin Diagn Lab Immunol, 2004,11 (4) :680-685.
  • 6Sahiner UM, Civelek E, Tuncer A, et al. Chronic urticaria: etio- lo-gy and natural course in children [ J]. Int Arch Allergy lmmu- nol, 2011,156(2) :224-230.
  • 7Aamir IS, Tanheed S, Majeed F, et al. Serum antithyroid anti- bodies in female patients with chronic urticaria [ J ]. J Coil Physi- cians Surg Pak, 2008,18(8) :498-501.
  • 8Shi CR, Li YP, Luo YJ, et al. IgE-mediated allergy : a rare cause of chronic spontaneous urticarial with allergen-specific immunoth- erapy as treatment option-a systematic review with meta-analysis from China [J]. J Eur Acad Dermatol Venereol, 2012,26(5) : 533-544.
  • 9Kasperska-Zajac A. Exacerbation of chronic urticaria in the cours- e of house dust mite immunotherapy [J. Hum Vaccin, 2011,7 (4) :417-418.
  • 10Wistokat-Wtilfing A, Schmidt P, Darsow U, et al. Atopy patch test reactions are associated with T lymphocyte-mediated allergen- specific immune responses in atopic dermatitis [ J]. Clin Exp Al- lergy, 1999,29(4) :513-521.

同被引文献138

  • 1王朴.生地黄的现代药理研究与临床应用[J].中国中医药现代远程教育,2008(8):986-986. 被引量:216
  • 2荨麻疹诊疗指南(2007版)[J].中华皮肤科杂志,2007,40(10):591-593. 被引量:213
  • 3乔秉善.变态反应实验技术[M].2版.北京:中国协和医科大学出版杜,2002:104-105.
  • 4奥多姆RB,詹姆斯WD,伯杰TG.徐世正译.安德鲁斯临床皮肤病学.9版.北京:科学出版社,2004,156-157.
  • 5Kessel A, Helou W, Bamberger E, et al. Elevaled serum total IgE-apotential marker for severe chronic urticaria. Int Arch Al- lergy Immunol, 2010,153 (3) :288-293.
  • 6Powell RJ, Du-Toit GL, Siddique N, et al. BSACI guidelines for the management of chronic urticaria and angio-oedema. Clin Exp Allergy, 2007,37 ( 5 ) : 631- 650.
  • 7Mahesh PA, Kushalappa PA, HoUa AD, et al. House dust mite sensitivity is factor in chronic urticaria. Indian J Dermatol Venereol Laeprol, 2005,71 (2) : 99-101.
  • 8Wan YG, Zhao Q, Sun W, et al. Contrasting dose-effects of multi-glycoside of Tripterygium wilfordii HOOK. f. on glomerular inflammation and hepatic damage in two types of anti-Thy1. 1 glomerulonephritis[J]. J Pharmaeol Sci, 2012,118(4) :433-446.
  • 9Godse KV, Nadkarni NJ, Jani G, et al. Fexofenadine in higher doses in chronic spontaneous urticaria[J]. Indian Dermatol Online J, 2010,1(1) :45-46.
  • 10Anvari E, Fred RG, Welsh N, et al. The Hi-receptor antagonist cetiri- zine protects partially against cytokine-and hydrogen peroxide-in- duced 15-TC6 cell death in vitro [ J ]. Pancreas, 2014,43 ( 4 ) : 624 - 629.

引证文献17

二级引证文献113

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部